In a 'real-world', clinic-based community setting, sorafenib dose of 400 mg/day is as effective as standard dose of 800 mg/day in patients with advanced hepatocellular carcimona, with better tolerance and similar survival. (Q37640588)
Jump to navigation
Jump to search
scientific article published on July 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | In a 'real-world', clinic-based community setting, sorafenib dose of 400 mg/day is as effective as standard dose of 800 mg/day in patients with advanced hepatocellular carcimona, with better tolerance and similar survival. |
scientific article published on July 2013 |
Statements
In a 'real-world', clinic-based community setting, sorafenib dose of 400 mg/day is as effective as standard dose of 800 mg/day in patients with advanced hepatocellular carcimona, with better tolerance and similar survival (English)
Alexandra Shingina
Al Moutaz Hashim
Mazhar Haque
Eric M Yoshida
Sharlene Gill
Fergal Donnellan
1 reference
1 reference
1 reference